SequelSEC

NEXGEL, INC. NXGL

Surgical & Medical Instruments & Apparatus · CIK 0001468929 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$12.07M
Fiscal year ended 2026-06-30
Operating income
-$5.40M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$11.03MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.25Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
R&D / revenue0.0%0th
CapEx / revenue0.6%11th
Gross margin39.5%19th
Current ratio1.47x24th
Revenue YoY growth31.5%75th
Operating margin-29.3%47th
Net margin-26.3%48th
FCF margin-12.1%49th
SBC / revenue5.7%50th

NEXGEL, INC. (NXGL) reported revenue of $12.07M and net income of -$6.18M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from NEXGEL, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

NEXGEL, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$12.07M
Cost of revenue$7.83M
Gross profit$4.23M
Operating income-$5.40M
Net income-$6.18M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$6.05M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$9.61M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

NEXGEL, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$26.45M
Current assets$6.17M
Total liabilities$20.98M
Current liabilities$14.44M
Total equity incl. NCI$5.47M
Temporary (mezzanine) equityUnavailable
Inventory$2.30M
Accounts receivable$1.08M
Goodwill$1.13M
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

NEXGEL, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$3.20M
Capital expendituresUnavailable
Investing cash flow-$6.64M
Financing cash flow$10.82M
Net change in cashUnavailable
Stock-based compensation$623.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.15M

Derived

NEXGEL, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin35.1%
Operating margin-44.8%
FCF marginUnavailable
SBC / revenue5.2%
Current ratio0.43x
Revenue YoY growth3.4%
Net margin-51.3%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NXGL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-17View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.